Trauma fixation devices industry is expected to witness significant demand over the forecast timeline owing to innovative and more effective technological developments that help improve overall patient care. These devices have witnessed revolutionary changes in terms of user friendliness and ease of operation in recent years. Enhanced devices such as bioresorbable implants, eluting implants as well as nano-coated devices will considerably drive the adoption of vital trauma fixation devices among hospitals and surgical centers.

Rising prevalence of road accidents is anticipated to strengthen trauma fixation devices industry outlook, as most of these incidents can lead to significant health repercussions. Road traffic crashes have

Elevating awareness about assisted reproduction procedures and various infertility treatments across developed as well as developing countries are predicted to drive surrogacy market trends in the coming years. High prevalence of infertility is expected to boost surrogacy practices to a large extent. As per the World Health Organization (WHO), one in every four couples in emerging countries is suffering from infertility.

Adoption of unhealthy & erratic lifestyles and increasing consumption of alcohol & tobacco are some prime factors that are contributing to increase cases of infertility. Additionally, problems associated with ovulation and fallopian tubes decrease the probability of childbearing in the women population.

Consistent adoption in clinical diagnosis and various medical research activities will stimulate the demand for next generation sequencing (NSG) tools. The surge in the number of chronic diseases like cancer, diabetes as well as inflammatory bowel ailments has fueled the need for advanced medicines and treatments. This has urged several pharmaceutical and biopharmaceutical companies to increasingly deploy NGS techniques as they are widely utilized to study genomes and identify issues arising in genes in disease development.

These firms are also keen on R&D investments to come up with alternative solutions and introduce personalized medicines for various diseases. Numerous refining regulatory as well as reimbursement framework

The animal diagnostics market is slated to record considerable proceeds over the coming years driven by an increase in technological developments in the field of molecular biology. The PCR (polymerase chain reaction) technology is extensively utilized for the genome sequencing of pathogens for the creation of essential elements that are used in disease diagnosis, parasite control, and biological research.

Numerous versions of PCR comprising nested PCR, Real-Time PCR (RT-PCR), and multiplex PCR have been designed for facilitating the diagnosis of veterinary ailments. In addition, numerous animal diagnostic companies are making investments in the development of diagnosis services, propelling business scenario.

Reque